Boston Scientific, Inc. BSX recently obtained a CE Mark on the Vercise Neural Navigator 5 Software with STIMVIEW XT technology. When used as an element of the Vercise Genus Deep Brain Stimulation (DBS ...
Optimal subthalamic nucleus deep-brain stimulation (STN-DBS) for Parkinson’s disease reduces motor symptoms without stimulating adjacent structures and causing side-effects. Fine-tuning STN-DBS using ...
Remote DBS programming improved Parkinson symptoms faster and reduced travel burdens, expanding access to specialized care. Living with Parkinson disease presents daily challenges that may ...
Deep brain stimulation (DBS) of the globus pallidus internus (GPi) is an established treatment for dystonia, yet the neurophysiological mechanisms underlying frequency-dependent effects remain poorly ...
The FDA approved Medtronic's BrainSense Adaptive DBS for Parkinson's, offering personalized therapy through automatic adjustments to patients' needs. The ADAPT-PD trial validated aDBS's safety and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results